Welcome To The Mannkind HUB On AGORACOM

Edit this title from the Fast Facts Section

Free
Message: Watch for MannKind to Potentially Rebound After Falling 3.18% Yesterday

The move from $8 to $13 occurred because the FDA said ACAD would not have to run a confirmatory trial.

Share
New Message
Please login to post a reply